KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Amortization of Deferred Charges (2016)

Historic Amortization of Deferred Charges for Charles River Laboratories International (CRL) over the last 7 years, with Q4 2016 value amounting to $506000.0.

  • Charles River Laboratories International's Amortization of Deferred Charges rose 2341.46% to $506000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $2.8 million, marking a year-over-year increase of 1894.96%. This contributed to the annual value of $2.8 million for FY2016, which is 1894.96% up from last year.
  • Per Charles River Laboratories International's latest filing, its Amortization of Deferred Charges stood at $506000.0 for Q4 2016, which was up 2341.46% from $34000.0 recorded in Q3 2016.
  • Charles River Laboratories International's Amortization of Deferred Charges' 5-year high stood at $4.6 million during Q1 2013, with a 5-year trough of $34000.0 in Q3 2016.
  • Its 5-year average for Amortization of Deferred Charges is $1.7 million, with a median of $436000.0 in 2013.
  • In the last 5 years, Charles River Laboratories International's Amortization of Deferred Charges surged by 16535.8% in 2015 and then tumbled by 9145.73% in 2016.
  • Over the past 5 years, Charles River Laboratories International's Amortization of Deferred Charges (Quarter) stood at $4.5 million in 2012, then tumbled by 90.26% to $437000.0 in 2013, then fell by 2.29% to $427000.0 in 2014, then decreased by 3.98% to $410000.0 in 2015, then grew by 23.41% to $506000.0 in 2016.
  • Its Amortization of Deferred Charges stands at $506000.0 for Q4 2016, versus $34000.0 for Q3 2016 and $1.9 million for Q2 2016.